302 related articles for article (PubMed ID: 16710035)
21. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer.
Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY
Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581
[TBL] [Abstract][Full Text] [Related]
22. Importance of MutL homologue MLH1 and MutS homologue MSH2 expression in Turkish patients with sporadic colorectal cancer.
Erdamar S; Ucaryilmaz E; Demir G; Karahasanoglu T; Dogusoy G; Dirican A; Goksel S
World J Gastroenterol; 2007 Sep; 13(33):4437-44. PubMed ID: 17724798
[TBL] [Abstract][Full Text] [Related]
23. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
[TBL] [Abstract][Full Text] [Related]
24. Bethesda guidelines: relation to microsatellite instability and MLH1 promoter methylation in patients with colorectal cancer.
Raedle J; Trojan J; Brieger A; Weber N; Schäfer D; Plotz G; Staib-Sebler E; Kriener S; Lorenz M; Zeuzem S
Ann Intern Med; 2001 Oct; 135(8 Pt 1):566-76. PubMed ID: 11601928
[TBL] [Abstract][Full Text] [Related]
25. Abnormal Fhit protein expression and high frequency of microsatellite instability in sporadic colorectal cancer.
Sarli L; Bottarelli L; Azzoni C; Campanini N; Di Cola G; Bader G; Iusco D; Salvemini C; Caruso G; Donadei E; Pizzi S; D'Adda T; Renato C; Roncoroni L; Bordi C
Eur J Cancer; 2004 Jul; 40(10):1581-8. PubMed ID: 15196543
[TBL] [Abstract][Full Text] [Related]
26. Evidence of a preferred molecular pathway in patients with synchronous colorectal cancer.
Dykes SL; Qui H; Rothenberger DA; García-Aguilar J
Cancer; 2003 Jul; 98(1):48-54. PubMed ID: 12833454
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of microsatellite instability determined by immunohistochemical staining of MSH2 and MLH1 in sporadic T3N0M0 colon cancer.
Parc Y; Gueroult S; Mourra N; Serfaty L; Fléjou JF; Tiret E; Parc R
Gut; 2004 Mar; 53(3):371-5. PubMed ID: 14960518
[TBL] [Abstract][Full Text] [Related]
28. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
[TBL] [Abstract][Full Text] [Related]
29. Microsatellite instability and promoter hypermethylation of MLH1 and MSH2 in patients with sporadic colorectal cancer.
Vlaykova T; Mitkova A; Stancheva G; Kadiyska T; Gulubova M; Yovchev Y; Cirovski G; Chilingirov P; Damyanov D; Kremensky I; Mitev V; Kaneva R
J BUON; 2011; 16(2):265-73. PubMed ID: 21766496
[TBL] [Abstract][Full Text] [Related]
30. Microsatellite instability in colorectal carcinoma. The comparison of immunohistochemistry and molecular biology suggests a role for hMSH6 [correction of hMLH6] immunostaining.
Rigau V; Sebbagh N; Olschwang S; Paraf F; Mourra N; Parc Y; Flejou JF
Arch Pathol Lab Med; 2003 Jun; 127(6):694-700. PubMed ID: 12741892
[TBL] [Abstract][Full Text] [Related]
31. Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer.
Chen Y; Wang J; Fraig MM; Henderson K; Bissada NK; Watson DK; Schweinfest CW
Int J Oncol; 2003 May; 22(5):1033-43. PubMed ID: 12684669
[TBL] [Abstract][Full Text] [Related]
32. Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregation.
Gill S; Lindor NM; Burgart LJ; Smalley R; Leontovich O; French AJ; Goldberg RM; Sargent DJ; Jass JR; Hopper JL; Jenkins MA; Young J; Barker MA; Walsh MD; Ruszkiewicz AR; Thibodeau SN
Clin Cancer Res; 2005 Sep; 11(18):6466-71. PubMed ID: 16166421
[TBL] [Abstract][Full Text] [Related]
33. Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors.
Hendriks Y; Franken P; Dierssen JW; De Leeuw W; Wijnen J; Dreef E; Tops C; Breuning M; Bröcker-Vriends A; Vasen H; Fodde R; Morreau H
Am J Pathol; 2003 Feb; 162(2):469-77. PubMed ID: 12547705
[TBL] [Abstract][Full Text] [Related]
34. Histopathology and mismatch repair status of 458 consecutive colorectal carcinomas.
Wright CL; Stewart ID
Am J Surg Pathol; 2003 Nov; 27(11):1393-406. PubMed ID: 14576472
[TBL] [Abstract][Full Text] [Related]
35. Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer.
Bapat BV; Madlensky L; Temple LK; Hiruki T; Redston M; Baron DL; Xia L; Marcus VA; Soravia C; Mitri A; Shen W; Gryfe R; Berk T; Chodirker BN; Cohen Z; Gallinger S
Hum Genet; 1999 Feb; 104(2):167-76. PubMed ID: 10190329
[TBL] [Abstract][Full Text] [Related]
36. [Is immunohistochemistry for MLH1 and MSH2 proteins a useful method for detection of microsatellite instability in sporadic colorectal cancer?].
Do JH; Chang SK; Ahnn JY; Cha BK; Cheong SM; Kim DW; Cheong HR; Kim HJ; Kim JG; Lee TJ; Park ES; Park SM
Korean J Gastroenterol; 2003 Nov; 42(5):369-76. PubMed ID: 14646573
[TBL] [Abstract][Full Text] [Related]
37. Mutations in MLH1 are more frequent than in MSH2 in sporadic colorectal cancers with microsatellite instability.
Herfarth KK; Kodner IJ; Whelan AJ; Ivanovich JL; Bracamontes JR; Wells SA; Goodfellow PJ
Genes Chromosomes Cancer; 1997 Jan; 18(1):42-9. PubMed ID: 8993979
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors and analysis of microsatellite instability in resected pulmonary metastases from colorectal carcinoma.
Melloni G; Doglioni C; Bandiera A; Carretta A; Ciriaco P; Arrigoni G; Zannini P
Ann Thorac Surg; 2006 Jun; 81(6):2008-13. PubMed ID: 16731121
[TBL] [Abstract][Full Text] [Related]
39. DNA mismatch repair deficiency in breast carcinoma: a pilot study of triple-negative and non-triple-negative tumors.
Wen YH; Brogi E; Zeng Z; Akram M; Catalano J; Paty PB; Norton L; Shia J
Am J Surg Pathol; 2012 Nov; 36(11):1700-8. PubMed ID: 22992699
[TBL] [Abstract][Full Text] [Related]
40. Deficiency of hMLH1 and hMSH2 expression is a poor prognostic factor in esophageal squamous cell carcinoma.
Uehara H; Miyamoto M; Kato K; Cho Y; Kurokawa T; Murakami S; Fukunaga A; Ebihara Y; Kaneko H; Hashimoto H; Murakami Y; Shichinohe T; Kawarada Y; Itoh T; Okushiba S; Kondo S; Katoh H
J Surg Oncol; 2005 Nov; 92(2):109-15. PubMed ID: 16231369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]